SFB 1526, PANTAU: Pathomechanismen Antikörpervermittelter Autoimmunerkrankungen

Sadik, Christian (Sprecher*in, Koordinator*in)
Zillikens, Detlef (Sprecher*in, Koordinator*in)
Scheffold, Alexander (Projektleiter*in (PI))
Schmidt, Enno (Projektleiter*in (PI))
Heine, Guido (Projektleiter*in (PI))
Manz, Rudolf (Projektleiter*in (PI))
Köhl, Jörg (Projektleiter*in (PI))
Ludwig, Ralf (Projektleiter*in (PI))
Peipp, Matthias (Projektleiter*in (PI))
Hammers, Matthias Christoph (Projektleiter*in (PI))
Verschoor, Admar (Projektleiter*in (PI))
Karsten, Christian (Projektleiter*in (PI))
Nimmerjahn, Falk (Projektleiter*in (PI))
Hutloff, Andreas (Projektleiter*in (PI))
Ibrahim, Saleh (Projektleiter*in (PI))
Wettschureck, Nina (Projektleiter*in (PI))
Bieber, Katja (Projektleiter*in (PI))
Schilf, Paul (Projektleiter*in (PI))
Vaeth, Martin (Projektleiter*in (PI))
Hirose, Misa (Projektleiter*in (PI))
Vaeth, Martin (Projektleiter*in (PI))
Baines, John F. (Projektleiter*in (PI))
Bacher, Petra (Projektleiter*in (PI))
Hoffmann, Markus (Projektleiter*in (PI))
Busch, Hauke Stephan (Projektleiter*in (PI))
Höppner, Marc (Projektleiter*in (PI))
Becker, Mareike (Projektleiter*in (PI))
Holtsche, Maike Marleen (Projektleiter*in (PI))
Fähnrich, Anke (Projektleiter*in (PI))
Szymczak, Silke (Projektleiter*in (PI))
Murthy, Sripriya (Projektleiter*in (PI))
Lux, Anja (Projektleiter*in (PI))

Projekt: DFG-Projekte › DFG-Verbundforschung: Sonderforschungsbereiche/ Transregios

45 Zeitschriftenaufsätze
14 Übersichtsarbeiten
7 Kommentare/Debatten
5 Briefe
Mehr
- 4 Kurzer Abriss

7 Ergebnisse

Filter

2023
Author Correction: Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus
Sigmund, A. M., Winkler, M., Engelmayer, S., Kugelmann, D., Egu, D. T., Steinert, L. S., Fuchs, M., Hiermaier, M., Radeva, M. Y., Bayerbach, F. C., Butz, E., Kotschi, S., Hudemann, C., Hertl, M., Yeruva, S., Schmidt, E., Yazdi, A. S., Ghoreschi, K., Vielmuth, F. & Waschke, J., 12.2023, in: Nature Communications. 14, 1, S. 665 665.
Publikation: Beiträge in Fachzeitschriften › Kommentare/Debatten
1 Zitat (Scopus)
Corrigendum: S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)
Antiga, E., Bech, R., Maglie, R., Genovese, G., Borradori, L., Bockle, B., Caproni, M., Caux, F., Chandran, N. S., Corrà, A., D'Amore, F., Daneshpazhooh, M., De, D., Didona, D., Dmochowski, M., Drenovska, K., Ehrchen, J., Feliciani, C., Goebeler, M. & Groves, R. &34 mehr, Günther, C., Handa, S., Hofmann, S. C., Horvath, B., Ioannidis, D., Jedlickova, H., Kowalewski, C., Kridin, K., Joly, P., Lim, Y. L., Marinovic, B., Maverakis, E., Meijer, J., Patsatsi, A., Pincelli, C., Prost, C., Setterfield, J., Sprecher, E., Skiljevic, D., Tasanen, K., Uzun, S., Van Beek, N., Vassileva, S., Vorobyev, A., Vujic, I., Wang, G., Wang, M., Wozniak, K., Yayli, S., Zambruno, G., Hashimoto, T., Schmidt, E., Mascarò, J. M. & Marzano, A. V., 11.2023, in: Journal of the European Academy of Dermatology and Venereology. 37, 11, S. 2378-2379 2 S.
Publikation: Beiträge in Fachzeitschriften › Kommentare/Debatten
Erratum zu: Immunpathogenese des Schleimhautpemphigoids
Schmidt, E. & Patzelt, S., 10.2023, in: Ophthalmologie. 120, 10, S. 1069-1070 2 S.
Publikation: Beiträge in Fachzeitschriften › Kommentare/Debatten
2022
Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)
Ghorbanalipoor, S., Emtenani, S., Parker, M., Kamaguchi, M., Osterloh, C., Pigors, M., Gross, N., Khil’chenko, S., Kasprick, A., Patzelt, S., Wortmann, D., Ibrahim, I. O., Izumi, K., Goletz, S., Boch, K., Kalies, K., Bieber, K., Smith, P., Schmidt, E. & Ludwig, R. J., 30.11.2022, in: Frontiers in Immunology. 13, 1099535.
Publikation: Beiträge in Fachzeitschriften › Kommentare/Debatten
2 Zitate (Scopus)
Current research and unmet needs in allergy and immunology in Germany: report presented by the DGfI and DGAKI task force Allergy & Immunology
Albrecht, M., Schaub, B., Gilles, S., Köhl, J., Altrichter, S., Voehringer, D., Spillner, E., Ehlers, M., Jönsson, F., Loser, K., Mayer, J. U., Rösner, L. M., Möbs, C., Heine, G. & Pfützner, W., 01.06.2022, in: European Journal of Immunology. 52, 6, S. 851-855 5 S.
Publikation: Beiträge in Fachzeitschriften › Kommentare/Debatten
Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
Boch, K., Langan, E. A., van Beek, N., Kridin, K., Schmidt, E., Zillikens, D., Ludwig, R. J., Hammers, C. M. & Bieber, K., 2022, in: Acta Dermato-Venereologica. 102, adv00835.
Publikation: Beiträge in Fachzeitschriften › Kommentare/Debatten
Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
Boch, K., Langan, E. A., Schmidt, E., Zillikens, D., Ludwig, R. J., Bieber, K. & Hammers, C. M., 25.03.2022, in: Acta Dermato-Venereologica. 102, adv00679.
Publikation: Beiträge in Fachzeitschriften › Kommentare/Debatten

SFB 1526, PANTAU: Pathomechanismen Antikörpervermittelter Autoimmunerkrankungen

Publikationen

Suchergebnisse

Author Correction: Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus

Corrigendum: S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)

Erratum zu: Immunpathogenese des Schleimhautpemphigoids

Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)

Current research and unmet needs in allergy and immunology in Germany: report presented by the DGfI and DGAKI task force Allergy & Immunology

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris